Glad to see a webinar happening, this is only a matter of time before we are rewarded for our patience I feel.
I can’t think of a better positioned company-
- Exo both being commercialised as a research tool as well as being internally developed in diagnostic and therapeutic uses
- SB2m continuing to be proved out as a superior marker individually and now in combination towards the “super” diagnostic test
- back burner projects BD and HTert
- excellent team Board and Executive.
DYOR
Ann: INOVIQ and Promega sign Global EXO-NET Agreement, page-14
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
0.185(39.8%) |
Mkt cap ! $59.81M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 80.0¢ | 63.0¢ | $3.071M | 4.375M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11091 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.5¢ | 5435 | 2 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
65.5¢ |
Change
0.185 ( 40.9 %) |
||||
| Open | High | Low | Volume | ||
| 72.5¢ | 77.5¢ | 63.0¢ | 508668 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| IIQ (ASX) Chart |